Full Press Release Details
STOUGHTON, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in May:
The SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on Tuesday, May 7th in New York City. Management will participate in investor meetings.
The RBC Capital Markets Global Healthcare Conference on Wednesday, May 22nd in New York City. Management will present at 2:05 p.m. ET and will also participate in investor meetings.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.